This exclusive seminar - organised by Canning House in partnership with Baker McKenzie – brings together multiple stakeholders from the UK and Latin America to delve into shared learnings, best practices, and opportunities for UK-Latin American collaboration in healthcare. This timely discussion aims to shed light on underexplored perspectives in today’s shifting global healthcare landscape.
Conference
Catalysing Healthcare Innovation across the UK and Latin America
- London
- 16:00-18:45 GMT + networking
The global healthcare landscape is undergoing a profound transformation, shaped by multiple trends including technological advances, supply chain demands, regulatory changes, shifting patient demands, and ESG concerns amongst other. This interplay of disruptions presents a valuable opportunity for building more resilient and innovative healthcare systems.
The current interplay of disruptive forces can - and must - be seized as a window for innovation in global healthcare. This exclusive seminar - organised by Canning House in partnership with Baker McKenzie – will bring together multiple stakeholders from the UK and Latin America to delve into shared learnings, best practices, and opportunities for UK-Latin American collaboration. This timely discussion aims to shed light on underexplored perspectives in today’s shifting global healthcare landscape.
In focus will be key themes ranging from adapting business models to current headwinds, market access challenges, the impact of AI, and how to navigate through a fragmented regulatory landscape and overcome geopolitical challenges.
-
Catalysing Healthcare Innovation across the UK and Latin America
-
Guests' arrival and registration
16:00-16:30
-
OPENING REMARKS
Jeremy Browne – CEO, Canning House
Baker McKenzie representative (TBC)
16:30-16:40
-
PANEL ONE
Adapting Business Models to Current Headwinds
Join our panel to explore how Mergers and Acquisitions (M&A) are increasingly seen as strategic tools for healthcare and life science companies across the UK, Iberia and Latin America to build robust portfolios, especially in response to patent cliffs and pricing pressures. By diversifying deal structures, such as through M&A and licensing, these companies can promote funding and innovation. However, market access remains a significant challenge due to rising costs, fragmented regulatory environments, and reimbursement issues. The impact of AI and new technologies presents both opportunities and challenges. While there is potential to improve medical outcomes and reduce healthcare spending, healthcare and life science companies must navigate a fragmented regulatory landscape, manage data effectively, and address confidentiality and cybersecurity risks.
Chair: Henrique Frizzo, Partner - Trench Rossi Watanabe*
Speakers: Information to follow...
*Trench Rossi Watanabe and Baker McKenzie have executed a strategic cooperation agreement for consulting on foreign law.
16:40-17:25
-
FIRESIDE CHAT
More information to follow...
17:25-17:50
-
PANEL TWO
Navigating Political Risk
Geopolitical crises are becoming the new normal. Healthcare and life science companies operating between the UK, Iberia and Latin America need to be aware of increasing geopolitical risks and trends to ensure supply chain stability, regulatory compliance, and make informed investment decisions for operational continuity. This panel will explore these critical issues alongside how to mitigate supply chain impacts, including diversification, increased local sourcing, and navigating complex sanctions regimes in key regions within the healthcare and life sciences sector today.
Chair: Sunny Mann, Partner - Baker McKenzie
Speakers: Information to follow...
17:50-18:35
-
CLOSING REMARKS
Jeremy Browne, CEO - Canning House
Baker McKenzie representative (TBC)
18:35-18:45
-
NETWORKING RECEPTION
18:45-19:30
Questions?
Please contact us with any questions about this event.
See our Events Terms & Conditions.
Share This Event
Share this event on social media using the buttons below.